Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zappe

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
The American Journal of Physiology|January 1, 1996
Age and regulation of fluid and electrolyte balance during repeated exercise sessionsD H Zappe, G W Bell, H Swartzentruber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patientsLeopoldo Raij, Brent M Egan, Dion H Zappe, et al.
Journal of Hypertension|August 16, 2011
Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patientsMatthew R Weir, Norman K Hollenberg, Giuseppe Remuzzi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trialWilliam B White, David A Calhoun, Rita Samuel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?Prakash C Deedwania, Dion H Zappe, Brent M Egan, et al.
Journal of Human Hypertension|December 17, 2009
Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertensionD H Zappe, B F Palmer, D A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|January 18, 2017
Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER StudyBryan Williams, John R Cockcroft, Kazuomi Kario, et al.
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.
The American Journal of Physiology|July 1, 1996
Cardiac output and renal function during insulin hypertension in Sprague-Dawley ratsM W Brands, W F Lee, H L Keen, et al.
BMJ Open|February 6, 2014
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) studyBryan Williams, John R Cockcroft, Kazuomi Kario, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
The American Journal of Physiology|January 1, 1996
Age and regulation of fluid and electrolyte balance during repeated exercise sessionsD H Zappe, G W Bell, H Swartzentruber, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 7, 2011
Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patientsLeopoldo Raij, Brent M Egan, Dion H Zappe, et al.
Journal of Hypertension|August 16, 2011
Varying patterns of the antihypertensive and antialbuminuric response to higher doses of renin-angiotensin-aldosterone system blockade in albuminuric hypertensive type 2 diabetes mellitus patientsMatthew R Weir, Norman K Hollenberg, Giuseppe Remuzzi, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|June 14, 2008
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trialWilliam B White, David A Calhoun, Rita Samuel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 4, 2012
Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?Prakash C Deedwania, Dion H Zappe, Brent M Egan, et al.
Journal of Human Hypertension|December 17, 2009
Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertensionD H Zappe, B F Palmer, D A Calhoun, et al.
Hypertension (Dallas, Tex. : 1979)|January 18, 2017
Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER StudyBryan Williams, John R Cockcroft, Kazuomi Kario, et al.
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.
The American Journal of Physiology|July 1, 1996
Cardiac output and renal function during insulin hypertension in Sprague-Dawley ratsM W Brands, W F Lee, H L Keen, et al.
BMJ Open|February 6, 2014
Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) studyBryan Williams, John R Cockcroft, Kazuomi Kario, et al.
Pageof 7